Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR)

PURPOSE: Clinical trial evidence has affirmed the role for immuno-oncology (IO) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC). This Study informing treatment Pathway dEcision in bladder cAnceR (SPEAR-Bladder) aimed to provide insight into the optimal sequencing of IO tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Doshi, Gurjyot K, Bhanegaonkar, Abhijeet, Kearney, Mairead, Bharmal, Murtuza, Cislo, Paul, Kim, Ruth, Boyd, Marley, Aguilar, Kathleen M, Phatak, Hemant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653272/
https://www.ncbi.nlm.nih.gov/pubmed/33192078
http://dx.doi.org/10.2147/CEOR.S264942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653272/
https://www.ncbi.nlm.nih.gov/pubmed/33192078
http://dx.doi.org/10.2147/CEOR.S264942

Ejemplares similares